Sfoglia per Autore
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
2016-01-01 Guerra, E.; Cimadamore, A.; Simeone, P.; Vacca, G.; Lattanzio, R.; Botti, G.; Gatta, V.; D'Aurora, M.; Simionati, B.; Piantelli, M.; Alberti, S.
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View
2017-01-01 Montironi, R.; Gasparrini, S.; Cimadamore, A.; Mazzucchelli, R.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Briganti, A.; Scarpelli, M.
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View
2017-01-01 Montironi, R.; Gasparrini, S.; Cimadamore, A.; Mazzucchelli, R.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Moch, H.; Montorsi, F.; Scarpelli, M.
Immunotherapy in genitourinary cancers: Where are we going?
2017-01-01 Bianconi, M.; Faloppi, L.; Lopez-Beltran, A.; Cheng, L.; Cimadamore, A.; Gasparrini, S.; Massari, F.; Scarpelli, M.; Montironi, R.
Are liver nested stromal epithelial tumors always low aggressive?
2017-01-01 Meletani, T; Cantini, L; Lanese, A; Nicolini, D; Cimadamore, A; Agostini, A; Ricci, Giulia; Antognoli, S; Mandolesi, A; Cortelazzo, GUIDO MARIA; Alaggio, R; Giuseppetti, Gm; Scarpelli, M; Vivarelli, M; Berardi, R.
Pathology and molecular updates in tumors of the prostate: towards a personalized approach
2017-01-01 Gasparrini, Silvia; Cimadamore, Alessia; Mazzucchelli, Roberta; Scarpelli, Marina; Massari, F; Raspollini, Mr; Galosi, Andrea Benedetto; Lopez Beltran, A; Cheng, L; Montironi, Rodolfo
Variants of Bladder Cancer: The Pathologist's Point of View
2017-01-01 Lopez-Beltran, A.; Cheng, L.; Raspollini, M. R.; Canas-Marques, R.; Scarpelli, M.; Cimadamore, A.; Gasparrini, S.; Montironi, R.
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets
2017-01-01 Cimadamore, Alessia; Scarpelli, Marina; Piva, Francesco; Massari, Francesco; Gasparrini, Silvia; Doria, Andrea; Cheng, Liang; Lopez beltran, Antonio; Montironi, Rodolfo
Whole slide imaging of large format histology in prostate pathology: Potential for information fusion
2017-01-01 Montironi, Rodolfo; Cimadamore, Alessia; Massari, Francesco; Montironi, Maria Alessandra; Lopez-Beltran, Antonio; Cheng, Liang; Montorsi, Francesco; Scarpelli, Marina
Epigenetic modifications and modulators in prostate cancer
2017-01-01 Cimadamore, A.; Gasparrini, S.; Scarpelli, M.; Doria, A.; Mazzucchelli, R.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
Long Non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression
2017-01-01 Cimadamore, Alessia; Gasparrini, Silvia; Mazzucchelli, Roberta; Doria, Andrea; Cheng, Liang; Lopez-Beltran, Antonio; Santoni, Matteo; Scarpelli, Marina; Montironi, Rodolfo
Re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, Rodolfo Montironi, Daniel W. Lin, Mahul B. Amin. Updates in the Eighth Edition of the Tumor-node-metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560–9: Tumour, Node, and Metastasis Staging System for Urological Malignancies: Are We Ready for the Next Step?
2018-01-01 Di Nunno, V.; Santoni, M.; Cimadamore, A.; Battelli, N.; Massari, F.
New prostate cancer targets for diagnosis, imaging, and therapy: Focus on prostate-specific membrane antigen
2018-01-01 Cimadamore, A.; Cheng, M.; Santoni, M.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Galosi, A. B.; Scarpelli, M.; Montironi, R.
Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma
2018-01-01 Montironi, R; Cimadamore, A; Gasparrini, S; Mazzucchelli, R; Santoni, M; Massari, F; Cheng, L; Lopez-Beltran, A; Scarpelli, M.
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer
2018-01-01 Cimadamore, A.; Gasparrini, S.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Giunchi, F.; Fiorentino, M.; Scarpelli, M.; Montironi, R.
Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy
2018-01-01 Cimadamore, A.; Scarpelli, M.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
Immunotherapy in renal cell carcinoma: latest evidence and clinical implications
2018-01-01 Santoni, M.; Massari, F.; Di Nunno, V.; Conti, A.; Cimadamore, A.; Scarpelli, M.; Montironi, R.; Cheng, L.; Battelli, N.; Lopez-Beltran, A.
Tivozanib for the treatment of renal cell carcinoma
2018-01-01 Santoni, Matteo; Massari, Francesco; Piva, Francesco; Carrozza, Francesco; Di Nunno, Vincenzo; Cimadamore, Alessia; Martignetti, Angelo; Montironi, Rodolfo; Battelli, Nicola
Emerging prognostic biomarkers in testicular germ cell tumors: Looking beyond established practice
2018-01-01 Chovanec, M.; Albany, C.; Mego, M.; Montironi, R.; Cimadamore, A.; Cheng, L.
Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors
2018-01-01 Santoni, Matteo; Piva, Francesco; Conti, Alessandro; Santoni, Angela; Cimadamore, Alessia; Scarpelli, Marina; Battelli, Nicola; Montironi, Rodolfo
Exploring small extracellular vesicles for precision medicine in prostate cancer
2018-01-01 Giulietti, Matteo; Santoni, Matteo; Cimadamore, Alessia; Carrozza, Francesco; Piva, Francesco; Cheng, Liang; Lopez-Beltran, Antonio; Scarpelli, Marina; Battelli, Nicola; Montironi, Rodolfo
Re: Isabel Rauscher, Charlotte Düwel, Bernhard Haller, et al. Efficacy, Predictive Factors, and Prediction Nomograms for 68Ga-labeled Prostate-specific Membrane Antigen–ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy. Eur Urol 2018;73:656–61: Clinical Significance of Prostate-specific Membrane Antigen Immunohistochemistry and Role of the Uropathologists
2018-01-01 Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montorsi, F.; Montironi, R.
The identification of immunological biomarkers in kidney cancers
2018-01-01 Lopez-Beltran, A.; Henriques, V.; Cimadamore, A.; Santoni, M.; Cheng, L.; Gevaert, T.; Blanca, A.; Massari, F.; Scarpelli, M.; Montironi, R.
Prostate cancer grading in 2018: Limitations, implementations, cribriform morphology, and biological markers
2018-01-01 Montironi, R.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.
Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
2018-01-01 Di Nunno, V.; Gatto, L.; Santoni, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Scarpelli, M.; Montironi, R.; Massari, F.
Emerging Molecular Technologies in Genitourinary Tumors
2018-01-01 Giunchi, Francesca; Cimadamore, Alessia; Fiorentino, Michelangelo
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer
2018-01-01 Di Nunno, Vincenzo; Cimadamore, Alessia; Santoni, Matteo; Scarpelli, Marina; Fiorentino, Michelangelo; Ciccarese, Chiara; Iacovelli, Roberto; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Montironi, Rodolfo
Quick steps toward precision medicine in renal cell carcinoma
2018-01-01 Massari, F.; Santoni, M.; Di Nunno, V.; Cimadamore, A.; Battelli, N.; Scarpelli, M.; Cheng, M.; Lopez-Beltran, A.; Cheng, L.; Montironi, R.
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies
2018-01-01 Massari, F.; Santoni, M.; di Nunno, V.; Cheng, L.; Lopez-Beltran, A.; Cimadamore, A.; Gasparrini, S.; Scarpelli, M.; Battelli, N.; Montironi, R.
Variants and new entities of bladder cancer
2019-01-01 Lopez-Beltran, A.; Henriques, V.; Montironi, R.; Cimadamore, A.; Raspollini, M. R.; Cheng, L.
Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers
2019-01-01 Santoni, M.; Cimadamore, A.; Massari, F.; Piva, F.; Aurilio, G.; Martignetti, A.; Scarpelli, M.; Di Nunno, V.; Gatto, L.; Battelli, N.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
The Prostatic Utricle and Endometrioid Prostate Cancer: Similarities, Differences and Challenges
2019-01-01 Montironi, R; Mazzucchelli, R; Gasparrini, S; Cimadamore, A; Galosi, Ab; Raspollini, Mr; Lopez-Beltran, A; Cheng, L; Scarpelli, M
Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor nodule
2019-01-01 Vau, N.; Henriques, V.; Cheng, L.; Blanca, A.; Fonseca, J.; Montironi, R.; Cimadamore, A.; Lopez-Beltran, A.
Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review
2019-01-01 Fiordoliva, Ilaria; Marcantognini, Giulia; Rinaldi, Silvia; Cimadamore, Alessia; Montironi, Rodolfo; Berardi, Rossana
Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go
2019-01-01 Gevaert, T.; Cimadamore, A.; Eckstein, M.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Montironi, R.
Editorial: Emerging biomarkers in genitourinary tumors
2019-01-01 Montironi, R.; Santoni, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.
The human microbiota and prostate cancer: Friend or foe?
2019-01-01 Massari, F.; Mollica, V.; Di Nunno, V.; Gatto, L.; Santoni, M.; Scarpelli, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Montironi, R.; Brandi, G.
Genitourinary tumors: Update on molecular biomarkers for diagnosis, prognosis and prediction of response to therapy
2019-01-01 Cimadamore, A.; Scarpelli, M.; Santoni, M.; Massari, F.; Tartari, F.; Cerqueti, R.; Lopez-Beltran, A.; Cheng, L.; Montironi, R.
Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer
2019-01-01 Blanca, A.; Sanchez-Gonzalez, A.; Requena, M. J.; Carrasco-Valiente, J.; Gomez-Gomez, E.; Cheng, L.; Cimadamore, A.; Montironi, R.; Lopez-Beltran, A.
Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype
2019-01-01 Rebola, J.; Aguiar, P.; Blanca, A.; Montironi, R.; Cimadamore, A.; Cheng, L.; Henriques, V.; Lobato-Faria, P.; Lopez-Beltran, A.
Microbiome and cancers, with focus on genitourinary tumors
2019-01-01 Cimadamore, A.; Santoni, M.; Massari, F.; Gasparrini, S.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Scarpelli, M.
Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples
2019-01-01 Volavsek, M.; Henriques, V.; Blanca, A.; Montironi, R.; Cheng, L.; Raspollini, M. R.; Cimadamore, A.; Vau, N.; Pierconti, F.; Lopez-Beltran, A.
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor
2019-01-01 Mollica, V.; Di Nunno, V.; Gatto, L.; Santoni, M.; Scarpelli, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Montironi, R.; Massari, F.
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution
2019-01-01 Mollica, V.; Di Nunno, V.; Gatto, L.; Santoni, M.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Pisconti, S.; Battelli, N.; Massari, F.
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians
2019-01-01 Gasparrini, S.; Cimadamore, A.; Scarpelli, M.; Massari, F.; Doria, A.; Mazzucchelli, R.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter
2019-01-01 Bianconi, M.; Cimadamore, A.; Faloppi, L.; Scartozzi, M.; Santoni, M.; Lopez-Beltran, A.; Cheng, L.; Scarpelli, M.; Montironi, R.
Circulating tumor cells in renal cell carcinoma: Recent findings and future challenges
2019-01-01 Santoni, M.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Scarpelli, M.; Galosi, A. B.; Bracarda, S.; Montironi, R.
RAS genes in colorectal carcinoma: Pathogenesis, testing guidelines and treatment implications
2019-01-01 Saeed, O.; Lopez-Beltran, A.; Fisher, K. W.; Scarpelli, M.; Montironi, R.; Cimadamore, A.; Massari, F.; Santoni, M.; Cheng, L.
Prostate Cancer Grading: Are We Heading Towards Grade Grouping Version 2?
2019-01-01 Montironi, R.; Cheng, L.; Cimadamore, A.; Lopez-Beltran, A.
Extramammary Paget disease of the penis closely mimicking the penile analogue of stratified mucin-producing intraepithelial lesion
2019-01-01 Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading | 1-gen-2016 | Guerra, E.; Cimadamore, A.; Simeone, P.; Vacca, G.; Lattanzio, R.; Botti, G.; Gatta, V.; D'Aurora, M.; Simionati, B.; Piantelli, M.; Alberti, S. | |
| Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View | 1-gen-2017 | Montironi, R.; Gasparrini, S.; Cimadamore, A.; Mazzucchelli, R.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Briganti, A.; Scarpelli, M. | |
| Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View | 1-gen-2017 | Montironi, R.; Gasparrini, S.; Cimadamore, A.; Mazzucchelli, R.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Moch, H.; Montorsi, F.; Scarpelli, M. | |
| Immunotherapy in genitourinary cancers: Where are we going? | 1-gen-2017 | Bianconi, M.; Faloppi, L.; Lopez-Beltran, A.; Cheng, L.; Cimadamore, A.; Gasparrini, S.; Massari, F.; Scarpelli, M.; Montironi, R. | |
| Are liver nested stromal epithelial tumors always low aggressive? | 1-gen-2017 | Meletani, T; Cantini, L; Lanese, A; Nicolini, D; Cimadamore, A; Agostini, A; Ricci, Giulia; Antognoli, S; Mandolesi, A; Cortelazzo, GUIDO MARIA; Alaggio, R; Giuseppetti, Gm; Scarpelli, M; Vivarelli, M; Berardi, R. | |
| Pathology and molecular updates in tumors of the prostate: towards a personalized approach | 1-gen-2017 | Gasparrini, Silvia; Cimadamore, Alessia; Mazzucchelli, Roberta; Scarpelli, Marina; Massari, F; Raspollini, Mr; Galosi, Andrea Benedetto; Lopez Beltran, A; Cheng, L; Montironi, Rodolfo | |
| Variants of Bladder Cancer: The Pathologist's Point of View | 1-gen-2017 | Lopez-Beltran, A.; Cheng, L.; Raspollini, M. R.; Canas-Marques, R.; Scarpelli, M.; Cimadamore, A.; Gasparrini, S.; Montironi, R. | |
| Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets | 1-gen-2017 | Cimadamore, Alessia; Scarpelli, Marina; Piva, Francesco; Massari, Francesco; Gasparrini, Silvia; Doria, Andrea; Cheng, Liang; Lopez beltran, Antonio; Montironi, Rodolfo | |
| Whole slide imaging of large format histology in prostate pathology: Potential for information fusion | 1-gen-2017 | Montironi, Rodolfo; Cimadamore, Alessia; Massari, Francesco; Montironi, Maria Alessandra; Lopez-Beltran, Antonio; Cheng, Liang; Montorsi, Francesco; Scarpelli, Marina | |
| Epigenetic modifications and modulators in prostate cancer | 1-gen-2017 | Cimadamore, A.; Gasparrini, S.; Scarpelli, M.; Doria, A.; Mazzucchelli, R.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Montironi, R. | |
| Long Non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression | 1-gen-2017 | Cimadamore, Alessia; Gasparrini, Silvia; Mazzucchelli, Roberta; Doria, Andrea; Cheng, Liang; Lopez-Beltran, Antonio; Santoni, Matteo; Scarpelli, Marina; Montironi, Rodolfo | |
| Re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, Rodolfo Montironi, Daniel W. Lin, Mahul B. Amin. Updates in the Eighth Edition of the Tumor-node-metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560–9: Tumour, Node, and Metastasis Staging System for Urological Malignancies: Are We Ready for the Next Step? | 1-gen-2018 | Di Nunno, V.; Santoni, M.; Cimadamore, A.; Battelli, N.; Massari, F. | |
| New prostate cancer targets for diagnosis, imaging, and therapy: Focus on prostate-specific membrane antigen | 1-gen-2018 | Cimadamore, A.; Cheng, M.; Santoni, M.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Galosi, A. B.; Scarpelli, M.; Montironi, R. | |
| Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma | 1-gen-2018 | Montironi, R; Cimadamore, A; Gasparrini, S; Mazzucchelli, R; Santoni, M; Massari, F; Cheng, L; Lopez-Beltran, A; Scarpelli, M. | |
| Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer | 1-gen-2018 | Cimadamore, A.; Gasparrini, S.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Giunchi, F.; Fiorentino, M.; Scarpelli, M.; Montironi, R. | |
| Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy | 1-gen-2018 | Cimadamore, A.; Scarpelli, M.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Montironi, R. | |
| Immunotherapy in renal cell carcinoma: latest evidence and clinical implications | 1-gen-2018 | Santoni, M.; Massari, F.; Di Nunno, V.; Conti, A.; Cimadamore, A.; Scarpelli, M.; Montironi, R.; Cheng, L.; Battelli, N.; Lopez-Beltran, A. | |
| Tivozanib for the treatment of renal cell carcinoma | 1-gen-2018 | Santoni, Matteo; Massari, Francesco; Piva, Francesco; Carrozza, Francesco; Di Nunno, Vincenzo; Cimadamore, Alessia; Martignetti, Angelo; Montironi, Rodolfo; Battelli, Nicola | |
| Emerging prognostic biomarkers in testicular germ cell tumors: Looking beyond established practice | 1-gen-2018 | Chovanec, M.; Albany, C.; Mego, M.; Montironi, R.; Cimadamore, A.; Cheng, L. | |
| Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors | 1-gen-2018 | Santoni, Matteo; Piva, Francesco; Conti, Alessandro; Santoni, Angela; Cimadamore, Alessia; Scarpelli, Marina; Battelli, Nicola; Montironi, Rodolfo | |
| Exploring small extracellular vesicles for precision medicine in prostate cancer | 1-gen-2018 | Giulietti, Matteo; Santoni, Matteo; Cimadamore, Alessia; Carrozza, Francesco; Piva, Francesco; Cheng, Liang; Lopez-Beltran, Antonio; Scarpelli, Marina; Battelli, Nicola; Montironi, Rodolfo | |
| Re: Isabel Rauscher, Charlotte Düwel, Bernhard Haller, et al. Efficacy, Predictive Factors, and Prediction Nomograms for 68Ga-labeled Prostate-specific Membrane Antigen–ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy. Eur Urol 2018;73:656–61: Clinical Significance of Prostate-specific Membrane Antigen Immunohistochemistry and Role of the Uropathologists | 1-gen-2018 | Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montorsi, F.; Montironi, R. | |
| The identification of immunological biomarkers in kidney cancers | 1-gen-2018 | Lopez-Beltran, A.; Henriques, V.; Cimadamore, A.; Santoni, M.; Cheng, L.; Gevaert, T.; Blanca, A.; Massari, F.; Scarpelli, M.; Montironi, R. | |
| Prostate cancer grading in 2018: Limitations, implementations, cribriform morphology, and biological markers | 1-gen-2018 | Montironi, R.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M. | |
| Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer | 1-gen-2018 | Di Nunno, V.; Gatto, L.; Santoni, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Scarpelli, M.; Montironi, R.; Massari, F. | |
| Emerging Molecular Technologies in Genitourinary Tumors | 1-gen-2018 | Giunchi, Francesca; Cimadamore, Alessia; Fiorentino, Michelangelo | |
| Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer | 1-gen-2018 | Di Nunno, Vincenzo; Cimadamore, Alessia; Santoni, Matteo; Scarpelli, Marina; Fiorentino, Michelangelo; Ciccarese, Chiara; Iacovelli, Roberto; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Montironi, Rodolfo | |
| Quick steps toward precision medicine in renal cell carcinoma | 1-gen-2018 | Massari, F.; Santoni, M.; Di Nunno, V.; Cimadamore, A.; Battelli, N.; Scarpelli, M.; Cheng, M.; Lopez-Beltran, A.; Cheng, L.; Montironi, R. | |
| Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies | 1-gen-2018 | Massari, F.; Santoni, M.; di Nunno, V.; Cheng, L.; Lopez-Beltran, A.; Cimadamore, A.; Gasparrini, S.; Scarpelli, M.; Battelli, N.; Montironi, R. | |
| Variants and new entities of bladder cancer | 1-gen-2019 | Lopez-Beltran, A.; Henriques, V.; Montironi, R.; Cimadamore, A.; Raspollini, M. R.; Cheng, L. | |
| Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers | 1-gen-2019 | Santoni, M.; Cimadamore, A.; Massari, F.; Piva, F.; Aurilio, G.; Martignetti, A.; Scarpelli, M.; Di Nunno, V.; Gatto, L.; Battelli, N.; Cheng, L.; Lopez-Beltran, A.; Montironi, R. | |
| The Prostatic Utricle and Endometrioid Prostate Cancer: Similarities, Differences and Challenges | 1-gen-2019 | Montironi, R; Mazzucchelli, R; Gasparrini, S; Cimadamore, A; Galosi, Ab; Raspollini, Mr; Lopez-Beltran, A; Cheng, L; Scarpelli, M | |
| Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor nodule | 1-gen-2019 | Vau, N.; Henriques, V.; Cheng, L.; Blanca, A.; Fonseca, J.; Montironi, R.; Cimadamore, A.; Lopez-Beltran, A. | |
| Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review | 1-gen-2019 | Fiordoliva, Ilaria; Marcantognini, Giulia; Rinaldi, Silvia; Cimadamore, Alessia; Montironi, Rodolfo; Berardi, Rossana | |
| Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go | 1-gen-2019 | Gevaert, T.; Cimadamore, A.; Eckstein, M.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Montironi, R. | |
| Editorial: Emerging biomarkers in genitourinary tumors | 1-gen-2019 | Montironi, R.; Santoni, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L. | |
| The human microbiota and prostate cancer: Friend or foe? | 1-gen-2019 | Massari, F.; Mollica, V.; Di Nunno, V.; Gatto, L.; Santoni, M.; Scarpelli, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Montironi, R.; Brandi, G. | |
| Genitourinary tumors: Update on molecular biomarkers for diagnosis, prognosis and prediction of response to therapy | 1-gen-2019 | Cimadamore, A.; Scarpelli, M.; Santoni, M.; Massari, F.; Tartari, F.; Cerqueti, R.; Lopez-Beltran, A.; Cheng, L.; Montironi, R. | |
| Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer | 1-gen-2019 | Blanca, A.; Sanchez-Gonzalez, A.; Requena, M. J.; Carrasco-Valiente, J.; Gomez-Gomez, E.; Cheng, L.; Cimadamore, A.; Montironi, R.; Lopez-Beltran, A. | |
| Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype | 1-gen-2019 | Rebola, J.; Aguiar, P.; Blanca, A.; Montironi, R.; Cimadamore, A.; Cheng, L.; Henriques, V.; Lobato-Faria, P.; Lopez-Beltran, A. | |
| Microbiome and cancers, with focus on genitourinary tumors | 1-gen-2019 | Cimadamore, A.; Santoni, M.; Massari, F.; Gasparrini, S.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Scarpelli, M. | |
| Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples | 1-gen-2019 | Volavsek, M.; Henriques, V.; Blanca, A.; Montironi, R.; Cheng, L.; Raspollini, M. R.; Cimadamore, A.; Vau, N.; Pierconti, F.; Lopez-Beltran, A. | |
| Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor | 1-gen-2019 | Mollica, V.; Di Nunno, V.; Gatto, L.; Santoni, M.; Scarpelli, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Montironi, R.; Massari, F. | |
| Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution | 1-gen-2019 | Mollica, V.; Di Nunno, V.; Gatto, L.; Santoni, M.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Pisconti, S.; Battelli, N.; Massari, F. | |
| Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians | 1-gen-2019 | Gasparrini, S.; Cimadamore, A.; Scarpelli, M.; Massari, F.; Doria, A.; Mazzucchelli, R.; Cheng, L.; Lopez-Beltran, A.; Montironi, R. | |
| Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter | 1-gen-2019 | Bianconi, M.; Cimadamore, A.; Faloppi, L.; Scartozzi, M.; Santoni, M.; Lopez-Beltran, A.; Cheng, L.; Scarpelli, M.; Montironi, R. | |
| Circulating tumor cells in renal cell carcinoma: Recent findings and future challenges | 1-gen-2019 | Santoni, M.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Scarpelli, M.; Galosi, A. B.; Bracarda, S.; Montironi, R. | |
| RAS genes in colorectal carcinoma: Pathogenesis, testing guidelines and treatment implications | 1-gen-2019 | Saeed, O.; Lopez-Beltran, A.; Fisher, K. W.; Scarpelli, M.; Montironi, R.; Cimadamore, A.; Massari, F.; Santoni, M.; Cheng, L. | |
| Prostate Cancer Grading: Are We Heading Towards Grade Grouping Version 2? | 1-gen-2019 | Montironi, R.; Cheng, L.; Cimadamore, A.; Lopez-Beltran, A. | |
| Extramammary Paget disease of the penis closely mimicking the penile analogue of stratified mucin-producing intraepithelial lesion | 1-gen-2019 | Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montironi, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile